These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23670970)

  • 1. Genetic modifiers of cystic fibrosis-related diabetes.
    Blackman SM; Commander CW; Watson C; Arcara KM; Strug LJ; Stonebraker JR; Wright FA; Rommens JM; Sun L; Pace RG; Norris SA; Durie PR; Drumm ML; Knowles MR; Cutting GR
    Diabetes; 2013 Oct; 62(10):3627-35. PubMed ID: 23670970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic dissection of diabetes: facing the giant.
    Meyre D; Pare G
    Diabetes; 2013 Oct; 62(10):3338-40. PubMed ID: 24065794
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
    Wu Y; Li H; Loos RJ; Yu Z; Ye X; Chen L; Pan A; Hu FB; Lin X
    Diabetes; 2008 Oct; 57(10):2834-42. PubMed ID: 18633108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
    Tabara Y; Osawa H; Kawamoto R; Onuma H; Shimizu I; Miki T; Kohara K; Makino H
    Diabetes; 2009 Feb; 58(2):493-8. PubMed ID: 19033397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
    Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
    J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies.
    Herder C; Rathmann W; Strassburger K; Finner H; Grallert H; Huth C; Meisinger C; Gieger C; Martin S; Giani G; Scherbaum WA; Wichmann HE; Illig T
    Horm Metab Res; 2008 Oct; 40(10):722-6. PubMed ID: 18597214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.
    Lam AN; Aksit MA; Vecchio-Pagan B; Shelton CA; Osorio DL; Anzmann AF; Goff LA; Whitcomb DC; Blackman SM; Cutting GR
    J Clin Invest; 2020 Jan; 130(1):272-286. PubMed ID: 31581148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.
    Chauhan G; Spurgeon CJ; Tabassum R; Bhaskar S; Kulkarni SR; Mahajan A; Chavali S; Kumar MV; Prakash S; Dwivedi OP; Ghosh S; Yajnik CS; Tandon N; Bharadwaj D; Chandak GR
    Diabetes; 2010 Aug; 59(8):2068-74. PubMed ID: 20424228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population.
    Takeuchi F; Serizawa M; Yamamoto K; Fujisawa T; Nakashima E; Ohnaka K; Ikegami H; Sugiyama T; Katsuya T; Miyagishi M; Nakashima N; Nawata H; Nakamura J; Kono S; Takayanagi R; Kato N
    Diabetes; 2009 Jul; 58(7):1690-9. PubMed ID: 19401414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
    Ng MC; Park KS; Oh B; Tam CH; Cho YM; Shin HD; Lam VK; Ma RC; So WY; Cho YS; Kim HL; Lee HK; Chan JC; Cho NH
    Diabetes; 2008 Aug; 57(8):2226-33. PubMed ID: 18469204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis.
    Aksit MA; Ling H; Pace RG; Raraigh KS; Onchiri F; Faino AV; Pagel K; Pugh E; Stilp AM; Sun Q; Blue EE; Wright FA; Zhou YH; Bamshad MJ; Gibson RL; Knowles MR; Cutting GR; Blackman SM;
    Am J Hum Genet; 2022 Oct; 109(10):1894-1908. PubMed ID: 36206743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians.
    Rong R; Hanson RL; Ortiz D; Wiedrich C; Kobes S; Knowler WC; Bogardus C; Baier LJ
    Diabetes; 2009 Feb; 58(2):478-88. PubMed ID: 19008344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.
    Wen J; Rönn T; Olsson A; Yang Z; Lu B; Du Y; Groop L; Ling C; Hu R
    PLoS One; 2010 Feb; 5(2):e9153. PubMed ID: 20161779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population.
    Gamboa-Meléndez MA; Huerta-Chagoya A; Moreno-Macías H; Vázquez-Cárdenas P; Ordóñez-Sánchez ML; Rodríguez-Guillén R; Riba L; Rodríguez-Torres M; Guerra-García MT; Guillén-Pineda LE; Choudhry S; Del Bosque-Plata L; Canizales-Quinteros S; Pérez-Ortiz G; Escobedo-Aguirre F; Parra A; Lerman-Garber I; Aguilar-Salinas CA; Tusié-Luna MT
    Diabetes; 2012 Dec; 61(12):3314-21. PubMed ID: 22923468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.
    Cauchi S; Meyre D; Durand E; Proença C; Marre M; Hadjadj S; Choquet H; De Graeve F; Gaget S; Allegaert F; Delplanque J; Permutt MA; Wasson J; Blech I; Charpentier G; Balkau B; Vergnaud AC; Czernichow S; Patsch W; Chikri M; Glaser B; Sladek R; Froguel P
    PLoS One; 2008 May; 3(5):e2031. PubMed ID: 18461161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population.
    Nemr R; Almawi AW; Echtay A; Sater MS; Daher HS; Almawi WY
    Diabetes Res Clin Pract; 2012 Feb; 95(2):e37-40. PubMed ID: 22119613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of loci associated with type 2 diabetes in human tissues.
    Cotsapas C; Prokunina-Olsson L; Welch C; Saxena R; Weaver C; Usher N; Guiducci C; Bonakdar S; Turner N; LaCroix B; Hall JL
    Diabetologia; 2010 Nov; 53(11):2334-9. PubMed ID: 20703447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study.
    van Hoek M; Dehghan A; Witteman JC; van Duijn CM; Uitterlinden AG; Oostra BA; Hofman A; Sijbrands EJ; Janssens AC
    Diabetes; 2008 Nov; 57(11):3122-8. PubMed ID: 18694974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
    Omori S; Tanaka Y; Takahashi A; Hirose H; Kashiwagi A; Kaku K; Kawamori R; Nakamura Y; Maeda S
    Diabetes; 2008 Mar; 57(3):791-5. PubMed ID: 18162508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.